Data protection Impressum

Newsroom

Distalmotion has received FDA approval for its Dexter Surgical Robot, allowing it to enter the U.S. outpatient market.

Distalmotion secures FDA approval for its Dexter surgical robot

29 October 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (October 2024)

29 October 2024

ATANIS Biotech, a leader in allergy diagnostics, has raised capital to advance its novel allergy test, FAST-PASE.

ATANIS Biotech secures new funding to launch its FAST-PASE allergy diagnostic test

28 October 2024

ONWARD Medical has raised EUR 50 million through an upsized private placement, establishing a strategic partnership with Ottobock. The funds will drive ONWARD’s research and commercialization of spinal cord therapies, with plans for collaboration with Ottobock on future innovations.

ONWARD Medical raises EUR 50 million and welcomes a new strategic partner

28 October 2024

Three Geneva-based start-ups - Dyneo Technologies, Adoram Therapeutics and ex vivo - have received CHF 250,000 from the FONGIT Innovation Fund to advance solutions in cleantech, life sciences and virtual reality.

Three innovative Geneva-based start-ups receive FIF funding

28 October 2024

Certification Experts, a division of Kader Group, has opened a new office on Lausanne's Biopôle campus, reinforcing its presence in Switzerland to meet rising demand for compliance and regulatory consulting in the medical device and pharmaceutical sectors.

Certification Experts expands medtech services with new office at Biopôle

28 October 2024

The Swiss Institute of Bioinformatics has inaugurated its Centre for Pathogen Bioinformatics in Lausanne to enhance pathogen research and surveillance.

SIB launches the Centre for Pathogen Bioinformatics to strengthen global pandemic response

28 October 2024

CloudBees, a global leader in software development platforms, has achieved a major milestone by surpassing USD 150 million in annual recurring revenue and reaching profitability.

Neuchâtel unicorn CloudBees reaches USD 150 million in revenue and becomes profitable

23 October 2024

Lonza expands its collaboration with a major biopharma partner, adding a new bioconjugation suite in Visp to support advanced cancer therapy manufacturing.

Lonza expands its manufacturing capabilities in Visp and creates 100 new jobs

23 October 2024

Nestled in the quiet industrial zone of Domdidier, in the canton of Fribourg, Medistri has grown into a key player in the highly specialized field of sterilization for medical and pharmaceutical industries.

Medistri, Fribourg’s hidden champion in medtech and pharmaceutical sterilization

22 October 2024

1 … 13 14 15 16 17 18 19 20 21 … 138